TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) (Terumo Corporation)
Welcome to the PulseAid listing for the TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) drug offered from Terumo Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Terumo Corporation |
| NON-PROPRIETARY NAME: | Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) |
| SUBSTANCE NAME: | ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE; ADENINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-12-10 |
| END MARKETING DATE: | 0000-00-00 |
TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) HUMAN PRESCRIPTION DRUG Details:
| Item Description | TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) from Terumo Corporation |
| LABELER NAME: | Terumo Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.99; 26.3; 2.22; 31.9; .275(g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL) |
| START MARKETING DATE: | 2009-12-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53877-001_50927003-7f54-4a37-b343-a1160a24f529 |
| PRODUCT NDC: | 53877-001 |
| APPLICATION NUMBER: | NDA820528 |
Other ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE; ADENINE Pharmaceutical Manufacturers / Labelers:
